Amneal Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.312; its P/E ratio is -17.33; Amneal Pharmaceuticals is scheduled to report earnings on May 3, 2024, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 616.98M	$ 620.04M	$ 599.05M	$ 557.54M	$ 609.76M
Gross Profit	$ 189.83M	$ 232.53M	$ 220.02M	$ 178.19M	$ 215.39M
EBIT	$ -78.88M	$ 22.96M	$ 29.66M	$ -9.43M	$ 39.37M
EBITDA	$ -20.65M	$ 82.52M	$ 89.24M	$ 50.78M	$ 102.53M
Net Income Common Stockholders	$ -98.65M	$ 9.68M	$ 11.92M	$ -6.97M	$ -4.32M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 91.54M	$ 86.93M	$ 114.58M	$ 151.07M	$ 35.23M
Total Assets	$ 3.47B	$ 3.69B	$ 3.70B	$ 3.51B	$ 3.80B
Total Debt	$ 2.64B	$ 2.69B	$ 2.74B	$ 2.73B	$ 2.72B
Net Debt	$ 2.55B	$ 2.60B	$ 2.63B	$ 2.58B	$ 2.69B
Total Liabilities	$ 2.72B	$ 2.77B	$ 2.82B	$ 3.34B	$ 3.47B
Stockholders Equity	$ 19.78M	$ 330.86M	$ 318.17M	$ 292.89M	$ 298.42M
Cash Flow	-
Free Cash Flow	$ 106.06M	$ 64.82M	$ -18.13M	$ 127.23M	$ -34.76M
Operating Cash Flow	$ 135.82M	$ 77.48M	$ -4.98M	$ 137.25M	$ -23.29M
Investing Cash Flow	$ -31.69M	$ -9.57M	$ -18.65M	$ -9.28M	$ -11.47M
Financing Cash Flow	$ -100.83M	$ -86.58M	$ -12.26M	$ -12.90M	$ -22.17M

Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History

Income Statement >

Amneal Pharmaceuticals Debt to Assets

Balance Sheet >

Amneal Pharmaceuticals Cash Flow

Cash Flow >

Amneal Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing